Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients

NCT00221624 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

131

Enrollment

OTHER

Sponsor class

Conditions

HCV Infection
Hepatitis C, Chronic

Interventions

DRUG: Peginterferon alfa-2a
DRUG: ribavirin
DRUG: amantadine

Sponsor

University Hospital, Bordeaux

Collaborators

[object Object]